These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 2198644)

  • 21. Thrombolytic therapy: then and now.
    Cole PL
    Heart Lung; 1991 Sep; 20(5 Pt 2):542-51. PubMed ID: 1910023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiographic assessment of patency and reocclusion: preliminary results of the Dutch APSAC Reocclusion Multicenter Study (ARMS).
    Visser RF
    Clin Cardiol; 1990 Mar; Suppl 5():V45-7; discussion V67-72. PubMed ID: 2182241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost effectiveness of thrombolytic treatment for myocardial infarction: comparison of anistreplase, alteplase and streptokinase in 270 patients treated within 4 hours.
    Machecourt J; Dumoulin J; Calop J; Foroni L; Terisse MP; Henon T; Vanzetto G; Denis B; Bassand JP; Cassagnes J
    Eur Heart J; 1993 Jan; 14(1):75-83. PubMed ID: 8432296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thrombolysis in acute myocardial infarct].
    Erne P
    Ther Umsch; 1991 Aug; 48(8):527-34. PubMed ID: 1926013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of the patency and stroke rates following thrombolysis with streptokinase, alteplase, and anistreplase used to treat an acute myocardial infarction.
    Baxter-Jones CS; White HD; Anderson JL
    J Interv Cardiol; 1993 Mar; 6(1):15-23. PubMed ID: 10171637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase.
    Tebbe U; Windeler J; Boesl I; Hoffmann H; Wojcik J; Ashmawy M; Rüdiger Schwarz E; von Loewis P; Rosemeyer P; Hopkins G
    J Am Coll Cardiol; 1995 Aug; 26(2):365-73. PubMed ID: 7608436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Streptokinase. A pharmacoeconomic appraisal of its use in the management of acute myocardial infarction.
    Gillis JC; Goa KL
    Pharmacoeconomics; 1996 Sep; 10(3):281-310. PubMed ID: 10163575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anistreplase: a novel thrombolytic agent for acute myocardial infarction.
    Marinac JS; North DS; Stringer KA
    DICP; 1990 Jun; 24(6):607-15. PubMed ID: 2193460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thrombolytic therapy of myocardial infarction: practical management].
    Bonnet JL; Bory M
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):707-12. PubMed ID: 1530412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reocclusion following thrombolytic treatment in acute myocardial infarct].
    Modin G; Näslund E; Rehnquist N; Strandberg LE
    Nord Med; 1991; 106(1):4-7. PubMed ID: 1996231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, double-blind study comparing saruplase with streptokinase therapy in acute myocardial infarction: the COMPASS Equivalence Trial. Comparison Trial of Saruplase and Streptokinase (COMASS) Investigators.
    Tebbe U; Michels R; Adgey J; Boland J; Caspi A; Charbonnier B; Windeler J; Barth H; Groves R; Hopkins GR; Fennell W; Betriu A; Ruda M; Mlczoch J
    J Am Coll Cardiol; 1998 Mar; 31(3):487-93. PubMed ID: 9502624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Should inferior myocardial infarction be thrombolysed?].
    Tabone X; Vacheron A
    Arch Mal Coeur Vaiss; 1992 Apr; 85(4):449-52. PubMed ID: 1642506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical profile of saruplase: angiographic findings.
    Meyer J
    Int J Clin Pract Suppl; 1998 Nov; 99():9-15. PubMed ID: 10344035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Saruplase in Myocardial Infarction.
    Bär FW; Vermeer F; Michels R; Boland J; Meyer J; Hopkins G; Barth H; Grünzler WA
    J Thromb Thrombolysis; 1995; 2(3):195-204. PubMed ID: 10608024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation and comparison of the adverse effects of streptokinase and alteplase.
    Tisdale JE; Colucci RD; Ujhelyi MR; Kluger J; Fieldman A; Chow MS
    Pharmacotherapy; 1992; 12(6):440-4. PubMed ID: 1492007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of saruplase and alteplase in acute myocardial infarction. SESAM Study Group. The Study in Europe with Saruplase and Alteplase in Myocardial Infarction.
    Bär FW; Meyer J; Vermeer F; Michels R; Charbonnier B; Haerten K; Spiecker M; Macaya C; Hanssen M; Heras M; Boland JP; Morice MC; Dunn FG; Uebis R; Hamm C; Ayzenberg O; Strupp G; Withagen AJ; Klein W; Windeler J; Hopkins G; Barth H; von Fisenne MJ
    Am J Cardiol; 1997 Mar; 79(6):727-32. PubMed ID: 9070549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Summary of U.S. clinical trials program for evaluation of anistreplase.
    Anderson JL
    Clin Cardiol; 1990 Mar; Suppl 5():V33-8; discussion V67-72. PubMed ID: 2182239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new thrombolytic regimen for acute myocardial infarction using combination half dose tissue-type plasminogen activator with full dose streptokinase: a pilot study. KAMIT Study Group.
    Grines CL; Nissen SE; Booth DC; Branco MC; Gurley JC; Bennett KA; DeMaria AN
    J Am Coll Cardiol; 1989 Sep; 14(3):573-80. PubMed ID: 2504797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of early thrombolytic therapy (anistreplase versus streptokinase) on enzymatic and electrocardiographic infarct size in acute myocardial infarction. TEAM-2 Investigators.
    Karagounis L; Moreno F; Menlove RL; Ipsen S; Anderson JL
    Am J Cardiol; 1991 Oct; 68(9):848-56. PubMed ID: 1927942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reperfusion therapy for acute myocardial infarction. Which strategy for which patient?
    Boersma E; Steyerberg EW; Van der Vlugt MJ; Simoons ML
    Drugs; 1998 Jul; 56(1):31-48. PubMed ID: 9664197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.